Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07635901Not ApplicableCompleted

Exercise Intervention for Chemotherapy-Induced Peripheral Neuropathy

Role: lead

NCT07603830Completed

Personality Type, Leadership Style and Training Needs Among Nurses

Role: lead

NCT07497022Not ApplicableCompleted

Effectiveness of Mindful Attention Awareness Breathing on Attention and Wellbeing Among Undergraduate Students

Role: lead

NCT07588204Completed

Non Urgent Visit to Emergency Department

Role: lead

All 4 trials loaded